A less invasive method of determining the stage of suspected NSCLC (non-small cell lung cancer) leads to fewer unnecessary surgical interventions and the side effects that go with them, and appears to be more efficient too, researchers from the Leiden University Medical Center, the Netherlands, report in JAMA (Journal of the American Medical Association) this week. Approximately 1.35 million people worldwide are diagnosed with lung cancer annually, and 1.2 million die from it. The authors write that it is the most commonly diagnosed cancer, as well as being the most frequent cause of death...
More...
More...